RxDoctor Payments Data

Christina Sanders

Surgery · Williamsville, NYNPI 1811142532

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (42.0%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Teleflex LLC at 41.2% of the total. 2025 is the largest year on record at $12,729, more than ten times the $131 reported in 2019. Among surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$43,708in general payments, 2019–2025

Across 125 payments — averaging $349.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teleflex LLC$18K
  • CMR Surgical, Inc.$13K
  • Intuitive Surgical$12K
  • Apollo Endosurgery US Inc$538
  • W. L. Gore & Associates, Inc.$238
  • Medtronic$204
  • plus $540 from 6 others
$155,000in research payments, 2019–2025

Across 1 payment — averaging $155,000 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Activ Surgical, Inc.$155K

What the payments were for

  • Consulting fees$6,75015%
  • Speaking & faculty fees$18,37542%
  • Travel & lodging$10,20023%
  • Food & beverage$3,6598%
  • Education$4,50010%
  • Gifts$2241%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$43,708 in reported general payments places this provider in the 95th percentile of 1,596 surgery providers in New York.

See all surgery providers in New York

Medicare billing

Part B allowed, 2024
$3,378
Medicare patients
24
Services billed
40

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dexlansoprazole DrDexlansoprazole22$4,557
Sucralfate17$1,175
Omeprazole13$473
Pantoprazole Sodium17$412

Paid to pharmacies, not to this prescriber.

Other surgery in Williamsville

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →